Koji Yoshino

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Successful retreatment with dabrafenib and trametinib for cardiac metastases of BRAF-mutated melanoma after adjuvant therapy.

Successful retreatment with dabrafenib and trametinib for cardiac metastases of BRAF-mutated melanoma after adjuvant therapy.

Journal: European journal of dermatology : EJD

Published: August 28, 2026

Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer.

Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

Journal: The Journal of dermatology

Published: April 05, 2026

Cytokine Release Syndrome Induced by Combination Therapy With Nivolumab and Ipilimumab in Lower Palpebral Conjunctival Melanoma: A Case Report.

Cytokine Release Syndrome Induced by Combination Therapy With Nivolumab and Ipilimumab in Lower Palpebral Conjunctival Melanoma: A Case Report.

Journal: The Journal of dermatology

Published: March 09, 2026

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor.

Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Journal: The British journal of dermatology

Published: October 22, 2025

Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 21, 2025

Showing 1-12 of 86

Last Updated: 09/26/2026